Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have

Catherine A Sabatos-Peyton1, James Nevin2, Ansgar Brock3

  • 1Exploratory Immuno-oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, USA.

Oncoimmunology
|January 9, 2018
PubMed

Insights

Blocking Tim-3 (T-cell immunoglobulin and mucin-domain containing-3) is crucial for effective anti-tumor immunity. This study shows that successful cancer immunotherapies targeting Tim-3 interfere with its binding to phosphatidylserine and CEACAM1.

Area of Science:

  • Immunology
  • Cancer Biology
  • Drug Development

Background:

  • Tim-3 (T-cell immunoglobulin and mucin-domain containing-3) blockade shows promise in preclinical cancer models and patient T cells for enhancing anti-tumor immunity.
  • Clinical development of anti-Tim-3 antibody therapeutics is of significant interest for cancer immunotherapy.
  • Multiple Tim-3 ligands (galectin-9, phosphatidylserine, HMGB1, CEACAM1) complicate therapeutic strategies, raising questions about which interactions are critical for efficacy.

Purpose of the Study:

  • To investigate the binding properties of functional anti-murine and anti-human Tim-3 antibodies.
  • To determine which Tim-3 ligand interactions are affected by efficacious anti-Tim-3 antibodies.
  • To inform the development and screening of anti-Tim-3 antibody candidates for cancer immunotherapy.

Main Methods:

  • Characterization of anti-murine and anti-human Tim-3 antibodies.
  • Assessment of antibody binding to Tim-3.
  • Evaluation of the impact of antibody binding on Tim-3 interactions with its ligands, including phosphatidylserine and CEACAM1.

Main Results:

  • All tested functional anti-Tim-3 antibodies bind to Tim-3.
  • This binding interferes with Tim-3's interaction with both phosphatidylserine and CEACAM1.
  • The findings provide insights into the mechanism of action for effective Tim-3 blockade.

Conclusions:

  • Effective anti-Tim-3 antibodies function by disrupting Tim-3 binding to specific ligands, notably phosphatidylserine and CEACAM1.
  • Understanding these critical receptor-ligand interactions is essential for the rational design and selection of anti-Tim-3 antibody therapeutics.
  • This research aids in the development of more effective cancer immunotherapies targeting the Tim-3 pathway.

Related Concept Videos

ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH301:11

ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
7.6K
Piaget's Stage 3 of Cognitive Development01:17

Piaget's Stage 3 of Cognitive Development

During Piaget's concrete operational stage, from ages 7 to 11, children exhibit a marked increase in logical thinking skills, specifically in relation to tangible, real-world events. This stage is characterized by the development of several essential cognitive concepts, including conservation, reversibility, and classification, all of which support the child's evolving capacity for structured thought.
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
1.1K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.1K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
715
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
239
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.8K